Tectonic Therapeutic, Inc. Cash Flow-to-Debt Ratio
Tectonic Therapeutic, Inc. cash flow-to-debt ratio. Tectonic Therapeutic, Inc. (TECX) has a Cash Flow-to-Debt Ratio of -1.63x as of June 2026, meaning its operating cash flow of $-21.45 Million could theoretically repay -2% of its total liabilities ($13.19 Million) in one year. See Tectonic Therapeutic, Inc. leverage flexibility ratio to measure the company's free cash flow as a share of total liabilities.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Cash Flow-to-Debt Ratio of Tectonic Therapeutic, Inc. (2016–2025)
Cash flow-to-debt ratio of Tectonic Therapeutic, Inc. from 2016 to 2025. Historical debt coverage capacity for Tectonic Therapeutic, Inc. across 10 annual periods. Also explore Tectonic Therapeutic, Inc. (TECX) equity growth momentum to track the company's year-over-year net asset growth rate.
Tectonic Therapeutic, Inc. Cash Flow-to-Debt Ratio by Year (2016–2025)
Tectonic Therapeutic, Inc. cash flow-to-debt ratio by year from 2016 to 2025. Year-by-year debt coverage analysis for Tectonic Therapeutic, Inc.. For the full cash flow conversion analysis, see Tectonic Therapeutic, Inc. (TECX) cash flow conversion.
| Year | CF-to-Debt Ratio | Operating CF (USD) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2025 | -6.19x | $-60.08 Million | $9.71 Million | ▼ -27.0% |
| 2024 | -4.87x | $-59.08 Million | $12.13 Million | ▼ -1385.1% |
| 2023 | -0.33x | $-40.68 Million | $124.03 Million | ▲ +68.7% |
| 2022 | -1.05x | $-97.21 Million | $92.86 Million | ▼ -302.1% |
| 2021 | -0.26x | $-12.45 Million | $47.84 Million | ▲ +95.5% |
| 2020 | -5.85x | $-98.80 Million | $16.89 Million | ▼ -25.4% |
| 2019 | -4.67x | $-67.67 Million | $14.50 Million | ▼ -40.0% |
| 2018 | -3.33x | $-37.65 Million | $11.29 Million | ▲ +25.6% |
| 2017 | -4.48x | $-16.38 Million | $3.66 Million | ▼ -32.3% |
| 2016 | -3.39x | $-3.31 Million | $979.00K | — |